4//SEC Filing
Lo Andrew 4
Accession 0001140361-22-033876
CIK 0001635088other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 9:53 PM ET
Size
7.1 KB
Accession
0001140361-22-033876
Insider Transaction Report
Form 4
Lo Andrew
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-09-15+71,850→ 71,850 totalExercise: $3.50Exp: 2032-09-14→ Common Shares (71,850 underlying) - Award
Common Shares
2022-09-15+52,142→ 52,142 total
Footnotes (2)
- [F1]Reflects an annual award of restricted stock units with respect to Common Shares ("RSUs") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 15, 2023, subject generally to the reporting person's continuous service through such date.
- [F2]Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 15, 2023, subject generally to the reporting person's continuous service through such date.
Documents
Issuer
Roivant Sciences Ltd.
CIK 0001635088
Entity typeother
Related Parties
1- filerCIK 0001679076
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 9:53 PM ET
- Size
- 7.1 KB